235 related articles for article (PubMed ID: 37104474)
1. M
Hassani SA; Neumann A; Russell J; Jones CK; Womelsdorf T
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216792120. PubMed ID: 37104474
[TBL] [Abstract][Full Text] [Related]
2. Modulation of arousal and sleep/wake architecture by M
Gould RW; Russell JK; Nedelcovych MT; Bubser M; Blobaum AL; Bridges TM; Newhouse PA; Lindsley CW; Conn PJ; Nader MA; Jones CK
Neuropsychopharmacology; 2020 Dec; 45(13):2219-2228. PubMed ID: 32868847
[TBL] [Abstract][Full Text] [Related]
3. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
[TBL] [Abstract][Full Text] [Related]
4. Probing the binding site of novel selective positive allosteric modulators at the M
Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
[TBL] [Abstract][Full Text] [Related]
6. M
Moran SP; Dickerson JW; Cho HP; Xiang Z; Maksymetz J; Remke DH; Lv X; Doyle CA; Rajan DH; Niswender CM; Engers DW; Lindsley CW; Rook JM; Conn PJ
Neuropsychopharmacology; 2018 Jul; 43(8):1763-1771. PubMed ID: 29581537
[TBL] [Abstract][Full Text] [Related]
7. A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.
Abd-Elrahman KS; Sarasija S; Colson TL; Ferguson SSG
Br J Pharmacol; 2022 Apr; 179(8):1769-1783. PubMed ID: 34820835
[TBL] [Abstract][Full Text] [Related]
8. M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?
Scarpa M; Hesse S; Bradley SJ
Adv Pharmacol; 2020; 88():277-310. PubMed ID: 32416870
[TBL] [Abstract][Full Text] [Related]
9. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M
Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ
ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284.
Smith DL; Davoren JE; Edgerton JR; Lazzaro JT; Lee CW; Neal S; Zhang L; Grimwood S
Mol Pharmacol; 2016 Sep; 90(3):177-87. PubMed ID: 27382013
[TBL] [Abstract][Full Text] [Related]
11. Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice.
Gould RW; Dencker D; Grannan M; Bubser M; Zhan X; Wess J; Xiang Z; Locuson C; Lindsley CW; Conn PJ; Jones CK
ACS Chem Neurosci; 2015 Oct; 6(10):1683-95. PubMed ID: 26176846
[TBL] [Abstract][Full Text] [Related]
12. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
[TBL] [Abstract][Full Text] [Related]
13. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
[TBL] [Abstract][Full Text] [Related]
14. M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss.
Bradley SJ; Bourgognon JM; Sanger HE; Verity N; Mogg AJ; White DJ; Butcher AJ; Moreno JA; Molloy C; Macedo-Hatch T; Edwards JM; Wess J; Pawlak R; Read DJ; Sexton PM; Broad LM; Steinert JR; Mallucci GR; Christopoulos A; Felder CC; Tobin AB
J Clin Invest; 2017 Feb; 127(2):487-499. PubMed ID: 27991860
[TBL] [Abstract][Full Text] [Related]
15. T-495, a novel low cooperative M
Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H
Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455
[TBL] [Abstract][Full Text] [Related]
16. Bitopic Binding Mode of an M
Bradley SJ; Molloy C; Bundgaard C; Mogg AJ; Thompson KJ; Dwomoh L; Sanger HE; Crabtree MD; Brooke SM; Sexton PM; Felder CC; Christopoulos A; Broad LM; Tobin AB; Langmead CJ
Mol Pharmacol; 2018 Jun; 93(6):645-656. PubMed ID: 29695609
[TBL] [Abstract][Full Text] [Related]
17. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.
Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM
J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308
[TBL] [Abstract][Full Text] [Related]
18. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.
Nikiforuk A; Kos T; Potasiewicz A; Popik P
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1300-13. PubMed ID: 26003081
[TBL] [Abstract][Full Text] [Related]
19. Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits.
Davie BJ; Christopoulos A; Scammells PJ
ACS Chem Neurosci; 2013 Jul; 4(7):1026-48. PubMed ID: 23659787
[TBL] [Abstract][Full Text] [Related]
20. A Novel M
Rook JM; Bertron JL; Cho HP; Garcia-Barrantes PM; Moran SP; Maksymetz JT; Nance KD; Dickerson JW; Remke DH; Chang S; Harp JM; Blobaum AL; Niswender CM; Jones CK; Stauffer SR; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2018 Sep; 9(9):2274-2285. PubMed ID: 29701957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
